SKYE
Skye BioscienceDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
SKYE vs peer average
48/100
SKYE vs. peer average (D vs. D)
Grade spread
B 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
APRE is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.46M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SKYE
Skye Bioscience
APRE
Aprea Therapeutics
Grade
D
D
Momentum
6
10
Value
59
56
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs APRE
SKYE / APRE
Grade Position
In line
SKYE vs. peer average (D vs. D)
48/100
Momentum
6
APREValue
59
SKYESentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SKYE
APRE is the first peer returned for this comparison set.